Skip to main content

ABO, Blood Group B Antigen Antibody (HEB-29)

Novus Biologicals, part of Bio-Techne | Catalog # NB120-2524

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NB120-2524SS
NB120-2524

Key Product Details

Species Reactivity

Human

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin, Agglutination

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgM Clone # HEB-29

Concentration

1.0 mg/ml

Product Specifications

Immunogen

Mixture of erythrocytes of blood group B and glycoprotein fraction isolated from the saliva of secretors with blood group B.

Specificity

The antibody HEB-29 reacts with human blood group B. The specifity of the antibody HEB-29 was confirmed by comparison of specifity and reactivity to standard reagent using >5.000 samples of blood.

Clonality

Monoclonal

Host

Mouse

Isotype

IgM

Description

Novus Biologicals Mouse ABO, Blood Group B Antigen Antibody (HEB-29) (NB120-2524) is a monoclonal antibody validated for use in IHC. Anti-ABO, Blood Group B Antigen Antibody: Cited in 2 publications. All Novus Biologicals antibodies are covered by our 100% guarantee.

Scientific Data Images for ABO, Blood Group B Antigen Antibody (HEB-29)

Agglutination: ABO, Blood Group B Antigen Antibody (HEB-29) [NB120-2524] - Agglutination of particular blood groups using mouse monoclonal HEB-29 (anti-blood group B).

Applications for ABO, Blood Group B Antigen Antibody (HEB-29)

Application
Recommended Usage

Immunohistochemistry

1:10-1:500

Immunohistochemistry-Paraffin

1:10-1:500
Application Notes
In agglutination tests, the minimum titre is 1:128 with erythrocytes of blood group B.

Formulation, Preparation, and Storage

Purification

Concentrated Supernatant

Formulation

Concentrated Supernatant

Preservative

No Preservative

Concentration

1.0 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C. Do not freeze.

Background: ABO, Blood Group B Antigen

Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Alternate Names

A transferase, A3GALNT, A3GALT1, ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase;transferase B, alpha 1-3-galactosyltransferase), ABO glycosyltransferase, B transferase, B(A) alpha-1,3-galactosyltransferase, EC 2.4.1.37, EC 2.4.1.40, Fucosylglycoprotein 3-alpha-galactosyltransferase, Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase, Glycoprotein-fucosylgalactoside alpha-galactosyltransferase, Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase, GTB, Histo-blood group A transferase, histo-blood group A2 transferase, histo-blood group ABO system transferase, Histo-blood group B transferase, NAGAT

Entrez Gene IDs

28 (Human)

Gene Symbol

ABO

UniProt

Additional ABO, Blood Group B Antigen Products

Product Documents for ABO, Blood Group B Antigen Antibody (HEB-29)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ABO, Blood Group B Antigen Antibody (HEB-29)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...